FDA.reportPublic FDA data

Oxervate 20 MCG/ML Ophthalmic Solution

RxCUI
2104341
RxNorm name
Oxervate 20 MCG/ML Ophthalmic Solution
Display name
Oxervate 20 MCG/ML Ophthalmic Solution
Full name
Oxervate 20 MCG/ML Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761094Oxervatecenegermin-bkbj351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OXERVATECENEGERMIN-BKBJDomp farmaceutici S.p.A.89e4bfec-d710-40ed-8885-5d13ba46b1cd2024-12-31Warnings, Adverse reactionsExact identifier
rxcui: 2104341

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89e4bfec-d710-40ed-8885-5d13ba46b1cdoxervate 0.002 % Ophthamic Solution [PSN] · cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [Oxervate] [SBD] · Oxervate 0.002 % Ophthamic Solution [SY] · Oxervate 0.02 MG/ML Ophthalmic Solution [SY] · Oxervate 20 MCG/ML Ophthalmic Solution [SY]514These highlights do not include all the information needed to use OXERVATE safely and effectively. See full prescribing information for OXERVATE. OXERVATE ® (cenegermin-bkbj) ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 201820250205